10 likes | 127 Views
Table 1 Outcomes in phase III trials of GO added to induction therapy in patients with previously untreated AML. Becker, H. & Bloomfield, C. D. ( 2013) En route to improved treatment options Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2012.239.
E N D
Table 1Outcomes in phase III trials of GO added to induction therapy in patients with previously untreated AML Becker, H. & Bloomfield, C. D. (2013) En route to improved treatment options Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2012.239